
1. open aids j. 2018 mar 12;12:11-19. doi: 10.2174/1874613601812010011. ecollection 
2018.

modification initial highly active antiretroviral therapy (haart) regimen in
paediatric hiv patients.

low ys(1), islahudin f(1), razali kam(2), adnan s(2).

author information: 
(1)faculty pharmacy, universiti kebangsaan malaysia, jalan raja muda abdul
aziz, 50300 kuala lumpur, malaysia.
(2)hospital kuala lumpur, jalan pahang, 50586 kuala lumpur, malaysia.

background: treatment options among human immunodeficiency virus (hiv)-infected
children limited highly active antiretroviral therapy (haart)
are approved worldwide paediatric use. among children, frequent changes in
haart regimen rapidly exhaust treatment options, information addressing
this issue scarce.
objective: aim study determine factors associated the
modification initial haart regimen modification among hiv-infected children.
method: retrospective study performed among hiv-infected children aged 18
and below, received haart least six months tertiary hospital 
malaysia. factors associated modification initial haart regimen were
investigated.
results: 99 patients, 71.1% (n=71) required initial haart regime
modification. common reason haart modification treatment failure
(n=39, 54.9%). reasons included drug toxicity (n=14, 19.7%), change to
fixed-dose products (n=11, 15.5%), product discontinuation (n=4, 5.6%) and
intolerable taste (n=3, 4.2%). overall mean time retention initial haart
before regimen modification 3.32 year Â± 2.24 years (95% ci, 2.79-3.85).
patient's adherence factor associated initial regimen
modification study. participants poor adherence showed five-fold
risk initial haart regimen modified compared good
adherence (adjusted [95% ci], 5.250 [1.614 - 17.076], p = 0.006).
conclusion: poor adherence significantly associated initial regimen
modification, intervention improve patient's adherence necessary prevent
multiple regimen modification among hiv-infected children.

doi: 10.2174/1874613601812010011 
pmcid: pmc5850481
pmid: 29576815 

